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Crystal Structures of E. coli Nicotinate
Mononucleotide Adenylyltransferase
and Its Complex with Deamido-NAD
dependent signaling pathways [4]. Because of the cen-
tral biochemical role played by NAD, the biosynthesis
and degradation of NAD has become a major focus of
investigation over the last few years.
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salvage routes [5–8]. All such pathways converge at the5323 Harry Hines Boulevard
Dallas, Texas 75390 reaction that links nicotinamide mononucleotide (NMN)
(or nicotinic acid mononucleotide [NaMN]) and ATP to3 Integrated Genomics, Inc.
2201 W. Campbell Park Drive form NAD (or deamido-NAD, NaAD) and inorganic py-
rophosphate (Figure 1). This reaction is catalyzed by theChicago, Illinois 60612
enzyme NMN or NaMN adenylyltransferase (NMNAT,
EC 2.7.7.1 or 2.7.7.18). NMNAT is indispensable in the
biosynthesis and salvage of NAD in all living organisms.Summary
In prokaryotes, NMNAT is absolutely essential for cell
survival and viability [9], which makes it an attractiveNicotinamide/Nicotinate mononucleotide (NMN/NaMN)
target for developing new antibacterial drugs. Intensiveadenylyltransferase is an indispensable enzyme in both
biochemical studies conducted on NMNAT from variousde novo biosynthesis and salvage of NAD and NADP.
species reveal that bacterial, eukaryotic, and archaealIn prokaryotes, it is absolutely required for cell survival,
NMNAT form three distinct subfamilies. They differ inthus representing an attractive target for the develop-
their oligomeric states, mononucleotide substrate spec-ment of new broad-spectrum antibacteria inhibitors. The
ificity, and sequence conservation patterns [7, 10–14].crystal structures of E. coli NaMN adenylyltransferase
Bacterial NMNATs exhibit various degrees of substrate(NMNAT) and its complex with deamido-NAD (NaAD)
preference for the deamidated NaMN over NMN [8, 15];revealed that ligand binding causes large conforma-
archaeal NMNAT strongly prefers NMN to NaMN [12,tional changes in several loop regions around the ac-
16]; while human and other eukaryotic NMNATs recog-tive site. The enzyme specifically recognizes the de-
nize both substrates almost equally well [7, 17–19]. Theamidated pyridine nucleotide through interactions
differences in the active site and subunit interfaces, asbetween nicotinate carboxylate with several protein
well as low sequence identity between bacterial andmain chain amides and a positive helix dipole. Com-
human NMNATs, suggest that differential inhibitors mayparison of E. coli NMNAT with those from archaeal
be found or designed.organisms revealed extensive differences in the active
Recently, the three-dimensional structures of NMNATsite architecture, enzyme-ligand interaction mode,
from M. jannaschii and M. thermoautotrophicum haveand bound dinucleotide conformations. The bacterial
been solved in complex with their substrates (ATP andNaMN adenylyltransferase structures described here
NMN) as well as with the product (NAD) [20, 21]. Se-provide a foundation for structure-based design of
quence and structural data for archaeal NMNAT showspecific inhibitors that may have therapeutic potential.
that it belongs to a large superfamily of nucleotidyltrans-
ferase / phosphodiesterases that possess a highly
Introduction conserved T/HXGH signature sequence motif and are
characterized by the presence of a dinucleotide binding
Nicotinamide adenine dinucleotides (NAD and NADP) fold (or Rossmann fold) [22]. Other members in this
are ubiquitous and essential in all living organisms. Their superfamily with known structures include phospho-
importance centers on their use as cofactors in hun- pantetheine adenylyltransferase (PPAT, protein ID
dreds of oxidation-reduction reactions throughout the COAD_ECOLI) [23], CTP:glycerol-3-phosphate cytidylyl-
cell. Together these nucleotides have a direct impact transferase (tagD gene product from B. subtilis) [24], the
on virtually every cellular metabolic pathway. Beyond a class I aminoacyl-tRNA synthetases, and, more recently,
role in redox reactions, NAD can also be used as a sulfate adenylyltransferase [25] and pantothenate syn-
substrate for the modification of proteins by ADP-ribo- thase [26]. All these functionally characterized enzymes
syltransferases and for the repair of DNA by DNA ligase cleave the /-phosphate bond of an NTP and transfer
in bacteria [1, 2]. The formation of protein-coupled the NMP to the second substrate. The reaction catalyzed
poly(ADP-ribose) facilitates survival of proliferating cells by NMNAT is believed to proceed via a nucleophilic
under conditions of DNA damage, probably via its contri- attack by the 5 phosphate of the mononucleotide on
bution to DNA base excision repair [3]. Recently, several the -phosphate of ATP. The highly conserved T/HXGH
NAD derivatives, such as cyclic ADP-ribose (cADPR) motif was shown to be involved in ATP binding, with
and nicotinic acid adenine dinucleotide phosphate the two histidine residue side chains interacting with the
(NaADP), have been reported to be potent intracellular
calcium-mobilizing agents participating in calcium-
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Figure 1. Reactions Catalyzed by NMNAT
Resulting in the Synthesis of NAD or NaAD
- and -phosphates of ATP, respectively, and probably nylyltransferase (pdb code 1g8f, Z  7.6), pantothenate
synthetase (pdb code 1iho, Z  6.4), and the catalyticdirectly participating in catalysis [20].
Because the sequence identity between archaeal core of glutaminyl-tRNA synthetase (pdb code 1gtr, Z
6.0). These structural superpositions help to establishNMNAT and its bacterial counterpart is low (18%) and
mostly clustered near the N terminus around the a structure-based multiple sequence alignment that
clearly reveals the distinct conservation pattern in theT/HXGH motif, a reliable sequence alignment between
these two subfamilies of NMNATs could not be achieved three subfamilies of NMNAT (Figure 3). Interestingly, the
structure of archaeal NMNAT appears to be more closelyprior to the solution of the structure of the E. coli enzyme.
It was also not possible to infer the bacterial enzyme related to bacterial PPAT (20% sequence identity, rmsd
2.2 A˚ over 143 C atoms [20]) than to its bacterial coun-active site based on the archaeal NMNAT structure.
Therefore, a high-resolution structure of a representa- terparts (see above). Both archaeal NMNAT and bacte-
rial PPAT proteins are of similar length and adopt thetive bacterial NMNAT and its complexes with substrates
are required in order to understand the enzyme’s active same fold topology that contains a central five-stranded
parallel  sheet and seven surrounding helices. There-site and substrate recognition mechanisms.
Here we report the crystal structures of E. coli NMNAT fore, bacterial and eukaryotic NMNATs appear to form
another structure/function family in the T/HIGH motif-(NadD_ECOLI, gi|1723307) in its apo-form and in com-
plex with deamido-NAD. These structures revealed containing nucleotidyltransferase superfamily, which is
distinct from the archaeal NMNAT and any other mem-gross differences in the active site and ligand interac-
tions compared to the archaeal enzyme as well as dras- bers of this superfamily.
tic conformational changes upon binding of NaAD. Our
data provide a structural basis for the substrate specific-
Structural Flexibility of apo-ecNMNATity of bacterial NMNAT.
In the P1 apo-form ecNMNAT crystal lattice, there are
four independent NMNAT molecules in the asymmetric
Results and Discussion unit that are related to each other by the general rota-
tional and translational operations. The different packing
Structure Description of apo-ecNMNAT interactions between each of the molecules indicate that
and Comparison with Other the oligomerization state of ecNMNAT should be mono-
Nucleotidyltransferases meric. This is consistent with the results of gel filtration
The E. coli NMNAT structure contains a central seven- studies (data not shown). Superposition of each ecNMNAT
stranded parallel  sheet flanked by several helices (Fig- molecules in the asymmetric unit indicates that several
ure 2A). Compared to the archaeal NMNAT structures regions are flexible and able to adopt multiple conforma-
[20, 21], the bacterial enzyme has an additional  tions (Figure 4A). Two of these flexible regions (residues
(DfEg) unit inserted at the C-terminal end of the  41–48 and 107–121) near the central cavity of the enzyme
sheet, which makes the total number of strands in the were later shown to undergo large conformational
central sheet seven instead of five, with four strands on changes upon binding of product NaAD (see below).
the second half of the pleated sheet after the crossover The third region (residues 140–148) is at the surface of
(Figure 2A). This topology provides yet another variation the molecule. The rmsd’s between the C traces of each
of the well-known dinucleotide binding fold, or Ross- of the four independent apo-ecNMNAT molecules range
mann-fold [27]. from 0.74 to 1.29A˚. This large difference, which is par-
A structure similarity search with DALI [28] using tially due to the different packing environment in the
ecNMNAT as the query indicates that ecNMNAT is most crystal lattice, certainly reflects the conformational flexi-
similar to E. coli PPAT (Protein Databank [pdb] code bility of the apo-enzyme structure in solution. This large
1b6t, Z score  14.7, identity 18%, rmsd  2.5A˚ over degree of structural flexibility may not only be necessary
145 Catoms out of a total of 157 residues), M. jannaschii for binding of substrates, but also for providing a mecha-
NMNAT (mjMNMNAT, pdb code 1f9a, Z  12.5, identity nism for product release [21].
18%, rmsd  3.0A˚ over 141 C atoms out of a total of
164 residues), and B. subtilis CTP:glycerol-3-phosphate
cytidylyltransferase (pdb code 1coz, Z  9.4, identity The Structure of ecNMNAT-NaAD Complex:
Ligand-Induced Conformational Changes22%, rmsd  3.0A˚ over 120 C atoms out of a total of
126 residues). To a lesser extend, ecNMNAT is also The intermolecular packing in the I222 lattice of the
cocrystal of ecNMNAT and NaAD is drastically differentsimilar to the adenylyltransferase domain of sulfate ade-
Structure of E. coli NaMN Adenylyltransferase
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Figure 2. Views of E. coli NMNAT Complex Structure
(A) Ribbon representation of E. coli NMNAT-NaAD and M. thermoautotrophicum NMNAT-NAD complex structures, as reproduced using the
program Molscript and Bobscript [41, 42]. The bound ligands are shown as sticks. The NaAD or NAD molecules are colored in red, while the
citrate and SO42 molecules are colored green. The secondary structure elements in the two structures are labeled correspondingly. They are
colored cyan for helices, yellow for strands, and gray for the portions that are not present in the other structure.
(B) Stereo view of the simulated annealed omit map for NaAD and citrate molecules in the ecNMNAT-NaAD structure. The map is contoured
at 3.0.
from that in the apo-form P1 crystal. There are three The overall rmsd’s between C atoms of each crystallo-
graphically independent complex and apo-ecNMNATcomplex molecules in the asymmetric unit, and they
are related by a 3-fold noncrystallographic symmetry. molecule in the two different lattices range from 1.20 A˚
to 1.46 A˚. Most of these conformational changes areHowever, gel filtration of the ecNMNAT-NaAD complex
showed a clean peak at 25 kDa position, indicating that located in three regions (labeled regions 1–3 in Figures
3 and 4A), where they are clearly beyond intrinsic struc-the complex exists as a monomer in solution. Therefore
the trimer appearance in the cocrystal is entirely due to tural flexibility. The first region is in the loop connecting
strand b and helix B (residue 41–48). In the apo-enzymecrystal packing and is not physiologically relevant. In
contrast to the apo-form ecNMNAT, the three indepen- structure, this loop is well ordered (average B factors are
around 30–40 A˚2) in each molecule, but its conformationdent molecules in the ecNMNAT-NaAD complex crystals
are very similar (Figure 4A). The rmsd differences in the varies significantly between molecules due to different
packing environments. In the complex structure, resi-C positions range from 0.29 A˚ to 0.43 A˚.
Large conformational differences are observed be- dues from this loop form intimate interactions with the
NaMN portion of NaAD (see below). The second largetween apo-ecNMNAT and the ecNMNAT-NaAD complex.
Structure
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Figure 3. Multiple Sequence Alignment of Representative Sequences of NMN/NaMN Adenylyltransferases (NMNAT, Genes Designated nadM
or nadD) and Closely Related Bacterial Phosphopantetheine Adenylyltransferase (PPAT, Gene Designated coaD)
Group A represents bacterial NMNAT sequences; group B represents eukaryotic NMNAT sequences; group C represents archaeal NMNAT
sequences, which also include a branch of bacterial NMNATs that are fused with a “Nudix” hydrolase domain [43]; group D represents bacterial
PPAT sequences. Each sequence is identified by the SWISS-PROT entry name, or in the absence of a SWISS-PROT annotation, by the NCBI
gene identification number (gi) followed by abbreviation of the species name. The identifiers of the sequences with known structures are
marked in red. The first and the last residue numbers of the sequences in each block are indicated, and the total length of the protein is
shown at the end. The number of omitted residues in the alignment is shown in parentheses. Diagram of the secondary structure elements
for E. coli NMNAT are shown at the top. The locations of the three regions that undergo large conformational changes upon ligand binding
are marked. Uncharged residues in mainly hydrophobic sites are highlighted in yellow. Functional residues discussed in the text are highlighted.
The species name abbreviations are as follows: Ps, Pseudomonas aeruginosa; Vc, Vibrio cholerae; Hs, Homo sapiens; Sc, Saccharomyces
cerevisiae; Sp, Schizosaccharomyces pombe; Ta, Thermoplasma acidophilum; Af, Archaeoglobus fulgidus; Dr, Deinococcus radiodurans. The
alignment revealed a likely error in the starting codon identification in sequence NADD_MYCTU, and a possible C-terminal frame shift in
NADD_AQUAE. The corrections to the original sequences are shown in italics and are underlined.
conformational change is in the region connecting occupying the potential pyridine binding site in the apo-
enzyme structure. Upon NaAD binding, the torsion anglestrand d and helix D (residue 107–120). This region is
particularly flexible in the apo-enzyme (avarage B fac- 1 of Trp-117 changed from 141	 to 69	, so that the
tryptophan ring now stacks under the nicotinate ringtors around 60 A˚2), with residues 112–120 completely
disordered in molecule B. However, it becomes well favorably. The conformational changes in this region
also bring Asp-109 and Ser-110 closer to the boundordered in the complex (average B factors around 30
A˚2). In addition to the main chain conformational ligand and allow them to interact with the 2-OH of the
AMP ribose (Figures 4B and 5A). The third flexible regionchanges, the side chain conformation of Trp-117
changes drastically in the complex (Figure 4B). It was is in the loop connecting strand e and helix D″ (residues
Structure of E. coli NaMN Adenylyltransferase
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Figure 4. Structural Flexibility and Ligand-
Induced Conformational Changes in E. coli
NMNAT
(A) Stereo drawing of the C superposition of
four crystallographically independent apoen-
zyme molecules (in blue) and three complex
molecules (in red).
(B) Stereo diagram of superposition of the
active site between apo-form (in yellow) and
complex (in cyan) E. coli NMNAT structures.
The bound NaAD (in orange) and citrate (in
green) are shown in ball-and-stick represen-
tation.
133–145). This loop is located at the beginning of the (mthNMNAT), but these two residues come from differ-
ent regions of the proteins (Figure 5B). Surprisingly, the insertion compared to the archaeal enzyme. It
forms part of the adenine binding pocket. This region is exocylic carboxylate group of the nicotinate does not
interact with any protein side chain groups. Instead, thewell ordered in the ligand-bound ecNMNAT, but shows
conformational flexibility in the apo-ecNMNAT structure main interactions between the enzyme and the nicoti-
nate carboxylate are formed with protein main chainsince it is located at the surface of the molecule and
lacks interactions with the surrounding protein atoms amides of Tyr-118 and Thr-85 (Figure 5A). One of the
nicotinate carboxylate oxygens is also hydrogen(Figure 4A). Upon binding of NaAD, this loop closes in
on the adenine, which brings the side chain of Arg-134 bonded to a water molecule, which in turn interacts with
the main chain amide of Ala-86. Additionally, helix C isto stack on top of the adenine ring and its guanidinium
group in position to interact with bound citrate molecule oriented in such a way that its N-terminal end is pointed
at the carboxylate of the nicotinate, so that its positive(Figure 4B). In connection with the conformational changes
around Arg-134, the Trp-176 side chain undergoes an dipole also contributes to the neutralization of the nega-
tive charge of the nicotinate.outward swing movement (1 changed 114	) in order to
accommodate the new conformation of Arg-134 (Figure As a result of the conformational changes in the loop
region 40–48, His-45 interacts with the NaMN-phos-4B). These conformational changes result in a more
closed active site which would bury over 90% of the phate, while Arg-46 forms electrostatic interactions with
the AMP-phosphate. Additionally, the side chain of Asn-surface area of the bound NaAD molecule.
40 interacts with the O2-hydroxyl of the NaMN-ribose.
From the multiple sequence alignment (Figure 3), aminoInteractions with NaAD
The ligand binding induced conformational changes re- acids at these three positions are conserved in their
properties in the bacterial NMNAT subfamily but aresult in a specific and tight binding of NaAD (Figure 5A).
Of particular interest is the recognition mechanism that varied in archaeal or eukaryotic NMNATs. In many bac-
terial NMNATs, Asn, Ser, or Thr is found at the Asn-40distinguishes nicotinic acid from nicotinamide. E. coli
NMNAT exhibits a profound substrate preference for position; aromatic residues Phe, His, or Gln replaces
His-45; and Arg or Lys is at the Arg-46 position. It isNaMN over NMN [15], with the ratio of the apparent
second order rate constant kcat/Km for the two substrates possible that these residues play a role in substrate
binding and/or catalysis. Further mutagenesis and kinet-exceeding 103-fold (O.K. et al., unpublished data). In the
complex structure, the nicotinate ring of NaAD forms ics studies will be required to determine the exact roles
of these residues.stacking interactions with side chains of Trp-117 and
His-45. The Trp-117 side chain is almost perfectly paral- The AMP portion of the dinucleotide also interacts
with the enzyme extensively (Figure 5A). The N6 aminolel to the pyridine ring. The role of Trp-117 is similar
to that of Trp-84 in M. thermoautotrophicum NMNAT group of the adenine ring forms hydrogen bonds with
Structure
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Figure 5. The Active Site of NMNAT
(A) Stereo diagram of the active site of E. coli
NMNAT with bound NaAD and citrate.
(B) Stereo diagram of the active site of M.
thermoautotrophicum NMNAT with bound
NAD, SO42 and Na. The bound ligands and
protein residues that are involved in ligand
binding are shown in ball-and-stick represen-
tation. The hydrogen bonds are indicated by
dotted lines.
the main chain carbonyl groups of residues Phe-177 is found in the complex with well-defined density (Figure
2B). The C1 and C3 carboxylates of the citrate moleculeand Ile-179. The N1 nitrogen interacts with the main
form bifurcated hydrogen bonds with the side chainschains of Arg-133 and Phe-177 through a water mole-
of Arg-134 and Arg-185, respectively (Figure 5A). Thecule. Additionally, the side chain of Arg-134 stacks over
carboxylate at the C2 position interacts with the mainthe adenine ring in a fashion similar to that observed
chain amides of Ala-181 and Thr-182. This C2 carboxyl-for the mjNMNAT Arg-121 [20]. The interactions of the
ate is also located near the N-terminal end of helix EAMP-ribose O2 hydroxyl with Asp-109 and Ser-110 side
and thus favorably interacts with the positive helix di-chains largely dictate the C2-endo pucker conforma-
pole. Ala-181 and Thr-182 are part of the highly con-tion. The AMP-phosphate is found to interact with the
served ISST motif present in many families of the T/HIGHside chain of Arg-46 and the main chain amides of Thr-
motif-containing nucleotidyltransferase superfamily [22].11 and Phe-12. Residues Thr-11 and Phe-12 are located
In many of these nucleotidyltransferase structures, anthree residues upstream of the T/HIGH motif and are
oxyanion hole exists near the ISST motif, which is cre-in the most conserved region, both sequentially and
ated by the combination of main chain amide nitrogens,structurally, in many nucleotidyltransferases (Figure 3).
conserved positively charged arginine side chains, andThree consecutive main chain amide groups from resi-
the positive dipole of the  helix containing the ISSTdues 11–13 point in the same direction and are able to
motif (helix E). This oxyanion hole forms the primaryinteract with the AMP-phosphate or the potential - and
binding site for the NTP phosphates, in particular the-phosphates of ATP. An invariant glycine residue im-
- and 
-phosphates. Superposition of the ecNMNATmediately preceding residue 11 is probably necessary
complex with the mjNMNAT-ATP complex [20] placesin order to avoid potential steric clash with the newly
the citrate C2 carboxylate in the same position as the
formed phosphoester bond.

-phosphate of the bound ATP in the mjNMNAT com-
plex. Therefore, the interactions with the negatively
Interactions with Citrate charged citrate molecule occupying this anion hole
Since there is 0.8 M Na citrate present in the crystalliza- would partially mimics the interactions between ATP
phosphates and the enzyme.tion solution, it is not surprising that a citrate molecule
Structure of E. coli NaMN Adenylyltransferase
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Figure 6. Comparision of the Structures of E.
coli and Archaeal NMNAT
Stereoview of the superposition of ecNMNAT
(cyan) and mthNMNAT (orange) structures,
centered at their active sites. The bound dinu-
cleotides are shown as sticks.
Active Site Comparison with Archaeal NMNAT of the pyridine nucleotide binding site in E. coli and
archaeal NMNATs are significantly different, about theSuperposition of the E. coli and archaeal NMNAT com-
plex structures reveals extensive differences in their ac- same number of interactions between substrate and
protein are present. Similar interactions often come fromtive site architecture and protein-ligand interactions
(Figures 5 and 6). The most conserved part of the active different parts of the protein. For example, in the
mthNMNAT complex structure, the Trp-84 side chainsite is around the adenine nucleotide binding pocket.
The nucleotidyltransferase signature T/HXGH motif in forms a stacking interaction with the pyridine ring, while
in ecNMNAT it is Trp-117 that plays the same role. Simi-E. coli and archaeal NMNATs adopt very similar confor-
mations, and the two His side chains are superimpos- larly, in mthNMNAT, Ser-36 and Asp-77 are in contact
with NMN-ribose O2 hydroxyl, while in ecNMNAT, Asn-able. They interact with the - and -phosphates of ATP,
respectively, as is shown in the M. jannaschii NMNAT- 40 interacts with the same O2 group. Another function-
ally equivalent but structurally different residue is Arg-8ATP complex [20]. Additionally, Arg-185 in the E. coli
enzyme, shown to interact with the bound citrate car- of mjNMNAT, compared to Arg-46 of ecNMNAT. Both
residues interact with the AMP-phosphate. Therefore, itboxylate, is superimposed with Arg-130 in mjNMNAT,
which interacts with the -phosphate of the bound ATP. is possible that the evolution of the bacterial/eukaryotic
and archaeal groups of NMNAT within the T/HIGH motif-One of the invariant residues in the archaeal NMNATs,
Arg-8 in mjNMNAT, was shown to interact with the containing nucleotidyltransferase superfamily may in-
volve functional convergence.
-phosphate of ATP. Corresponding residues in bacte-
rial and eukaryotic NMNATs are replaced by Ser or Thr As a result of the different substrate binding site ar-
rangements, the mthNMNAT-bound NAD and ecNMNAT-(Figure 3). However, the guanidinium group of the Arg-
46 side chain in ecNMNAT is now in a position similar bound NaAD adopt rather different conformations (Fig-
ure 6). In particular, the linkage between NMN riboseto that of Arg-8 in the M. jannaschii enzyme, and it
appears to play a similar role of interacting with the ATP and phosphate is changed from a trans conformation
in the mthNMNAT complex to cis in the ecNMNAT com-phosphates.
In contrast to the ATP binding site, the differences plex. Although the pyridine ribose conformations are
essentially the same, their positioning relative to thebetween the pyridine nucleotide binding pocket of the
E. coli and archaeal NMNATs are striking. Extensive AMP portion is significantly different. Another difference
is that the AMP ribose in the ecNMNAT-bound NaADdifferences in main chain conformations reshape the
nicotinamide/nicotinate binding pocket significantly adopts a C2-endo pucker, whereas it adopts a C3-
endo pucker in the mthNMNAT-bound NAD. It needs to(Figure 6). Archaeal NMNATs exhibit a strong preference
for the amidated form of NMN [12]. The mthNMNAT- be noted that in the mjNMNAT-ATP complex structure,
the ATP ribose also adopts a C2-endo pucker, whichNAD complex structure [21] shows that recognition of
NMN is achieved through several specific interactions is different from that of the bound product NAD. In the
ecNMNAT-NaAD complex, the O2 of the AMP-ribosewith the enzyme: the substituent carboxyamide group
of the nicotinamide is linked to the main chain of Ile-81, interacts with Asp-109 and Ser-110, while the hydroxyls
of the AMP ribose in the mthNMNAT bound NAD interactwith its oxygen to the amide and its nitrogen to the
carbonyl atoms (Figure 5B). Additionally, the side chain with the Gly-104 main chain amide and a water molecule.
Since there is no direct contact between ATP riboseof Asn-84 holds the -NH2 of the substituent in place.
The orientation of helix C in archaeal NMNAT differs and any protein atoms in the archaeal enzyme-ATP com-
plex, it is likely that, during catalysis, the adenine ribosefrom that of the E. coli enzyme by 45	 degrees, and
its N-terminal end is pointed away from the bound nico- changes its conformation from C2-endo to C3-endo
pucker.tinamide. Without major conformational changes, which
at least would require a flipping of the Ile-81/Glu-82 So far, no apo-form NMNAT from archaeal species
has been reported. However, it has been suggestedpeptide bond and a rotation of the Asn-84 side chain,
this site is clearly more favorable for the binding of NMN that significant conformational changes, presumably at
higher temperatures, are necessary for the product tothan NaMN.
It is interesting to note that although the architectures release [21]. In contrast to the monomeric ecNMNAT,
Structure
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Table 1. Crystal Data and Refinement Statistics of E. coli NMNAT and Its Complex with NaAD
SeMet NMNAT
Peak Inflection Apo-Form NaAD Complex
Space group P1 P1 P1 I222
Resolution (A˚) 2.5 2.5 2.0 1.9
Total observation 123,785 132,644 169,804 180,068
Unique Reflectionsa 67,179 70,741 62,463 57,802
Completeness (outer shell) 91.0% (69.1%) 96.4% (96.0%) 94.6% (81.9%) 95.5% (67.5%)
Rsym (outer shell)b 0.077 (0.428) 0.074 (0.388) 0.045 (0.250) 0.056 (0.355)
I/ (outer shell) 9.0 (1.0) 12.2 (2.0) 20.9 (4.0) 24.8 (1.8)
Refinement
Rworkc 21.0% 20.6%
Rfreed 26.2% 25.5%
Protein atoms 6,863 5,202
Hetero groups 4 Xe 3 NaAD, 3 Citrate
Water 585 510
Rmsd from ideal geometry
Rmsd bond length (A˚) 0.012 0.011
Rmsd bond angle (	) 1.70 1.61
Average B factors (A˚2)
Protein main chain 36.0 32.4
Protein side chain 39.8 35.0
Hetero groups 92.0 (Xe) 28.3 (NaAD)
40.3 (Citrate)
Solvent 44.0 42.4
Ramachandran plot
Most favored (%) 91.1 90.6
Additional (%) 8.9 9.4
Disallowed (%) 0 0
a The Fridel pairs are treated as independent reflections for the SeMet data sets.
b Rsym  hkl[(j|Ij  I|)/j|Ij].
c Rwork  hkl|Fo  Fc|/hkl|Fo|, where Fo and Fc are the observed and calculated structure factors, respectively.
d Rfree is the R factor calculated for a randomly selected 5% of the reflections that were omitted from the refinement.
archaeal NMNATs are hexameric. Interestingly, the plaining the high degree of substrate preference for
NaMN in the E. coli enzyme. Additionally, Trp-117 andclosely related bacterial PPAT is also hexameric, al-
His-45 form stacking interactions with the pyridine ring,though the interprotomer packing interactions are differ-
which restrict the orientation of the nicotinate ring asent from that in archaeal NMNAT [23]. In the PPAT hex-
well as its exocyclic carboxylate. Different positioningamer, only half of the active sites are able to bind
of the protein residues that interact with the bound dinu-dephospho-CoA, the product of the enzyme. Compari-
cleotide in E. coli and archaeal enzymes result in veryson of the ligand-free and ligand-bound PPAT proto-
different bound ligand conformations (Figure 6).mers shows that a 1 A˚ shift of helix E toward the
The structure-based sequence alignment reveals resi-adenine nucleotide binding site in the ligand-free PPAT
dues uniquely conserved in each subfamily of NMNATsprotomer may prevent it from binding the substrate.
that may define the unique properties of each subfamilyHowever, there are no other significant conformational
(Figure 3). One such residue is Asp-109, which is invari-changes between the apo- and ligand-bound PPAT
ant among prokaryotic and eukaryotic groups of NMNATsubunit.
but not conserved in the archaeal NMNATs. Superposi-
tion of the ecNMNAT-NaAD with mjNMNAT-Mg2-ATP
Structure Basis for the Substrate Specificity complex structures suggests that, in addition to inter-
and Catalytic Mechanism acting with the O2 hydroxyl group of adenosine ribose,
The structures of the apo-form and NaAD-bound this Asp may be in a position to bind a Mg2 ion, which
ecNMNAT reported here enable the identification of is required for NMNAT activity. Other residues, such
many active site residues that otherwise are impossible as His-45 and Arg-46, which are conserved in many
to infer from the archaeal enzyme structures. The com- bacterial enzymes, interact with NaAD in a way not ob-
plex structure helped to elucidate the structural determi- served in the archaeal NMNAT. Whether they are directly
nants of substrate preference for the deamidated NaMN involved in catalysis remains to be determined. It has
over NMN of E. coli and many other bacterial NMNATs. been proposed for the archaeal NMNAT and many other
It is shown that an anion binding pocket, created by the nucleotidyltransferases, such as PPAT and class I
main chain amide groups of Thr-85 and Tyr-118 as well aminoacyl-tRNA synthetase, that the adenylation reac-
as the positive dipole of  helix C forms the majority of tion proceeds via a transition state stabilization without
the interactions with the carboxylate group of NaMN covalent or acid-base involvement of protein residues
(Figure 5A). These interactions are highly discriminating [20, 23, 29, 30]. Based on the ecNMNAT-NaAD interac-
tions in the complex structure, ecNMNAT is likely tobetween nicotinic acid and nicotinamide, thus ex-
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preparation). Briefly, the E. coli nadD gene (open reading framehave a similar mechanism. Further structural analysis of
yben) was amplified from E. coli (strain DH5) genomic DNA by thetransition state complexes, mutagenesis, and kinetic
polymerase chain reaction and cloned into a pET-derived vectorstudies are required to verify this proposed mechanism
containing a T7 promoter, 6 His tag, and a TEV protease cleavage
and to elucidate the exact roles of individual key resi- site (gift from Dr. Meg Philips, UT Southwestern Medical Center). The
dues. The need for a substrate or transition state com- resulting plasmid was transformed into the E. coli strain BL21(DE3)
(GIBCO–BRL) for expression. The overexpressed ecNMNAT proteinplex structure is further substantiated by the observa-
was first purified with a Ni-NTA agarose (Qiagen) column. The 6tion that E. coli NMNAT exhibits product inhibition when
His tag was subsequently removed by treatment with TEV-proteasethe NaAD concentration is 1.0 mM [15]. Therefore,
produced in our laboratory using a construct kindly provided to usthe NMNAT-NaAD complex structure obtained in the
by Dr. David Waugh (NCI, Frederick, MD). The tag-removed ecNMNAT
presence of excess NaAD may not fully represent the was recovered in the flow-through of the Ni-NTA agarose column
active state of the enzyme. and was further purified on a Mono Q column (Pharmacia) followed
by a Superdex 75 gel filtration column (Pharmacia). The selenomethi-
onine ecNMNAT was expressed in the met auxotrophic strainBiological Implications
B834(DE3) (Novagen) grown in minimal medium supplemented with
selenomethionine and other nutrients as described in [31], and wasIn addition to its fundamental role as coenzyme in hun-
purified using the same procedure as the native protein.
dreds of oxidation-reduction reactions throughout the
cell, NAD can also be used as substrate for the modifica- Crystallization and Data Collection
tion of a variety of nuclear proteins by ADP ribosyltrans- E. coli NMNAT crystals were grown at 20	C using the hanging drop
vapor diffusion method. ecNMNAT (20 mg/ml) in 50 mM HEPES (pHferases and for the repair of DNA by DNA ligase in bacte-
7.2), 150 mM NaCl, and 1 mM DTT was mixed with an equal volumeria. The multiple roles of NAD in cellular functions
of the reservoir solution (0.1 M Tris, pH 7.0, 0.2 M NaCl, 0.8 M Nanecessitate that NAD biosynthesis must be actively reg-
citrate) and equilibrated against the reservoir. Large plate crystalsulated and proper NAD levels maintained. As an indis-
were grown over a period of two months to a maximal size of 0.7 
pensable enzyme catalyzing the central step in both 0.4  0.05 mm3. These apo-form ecNMNAT crystals belong to the
de novo and salvage pathways of NAD biosynthesis, P1 space group with cell dimensions a  58.4 A˚, b  66.5 A˚, c 
72.9 A˚,  72.7	,  88.8	, 
  69.6	, and diffract to 2.0 A˚ resolutionNMNAT has been shown to be essential for cell survival
on a rotating anode X-ray generator. There are four ecNMNAT mole-in prokaryotes [9], thus representing an attractive target
cules in the P1 asymmetric unit.for the development of new antibacterial drugs. An at-
The ecNMNAT-NaAD cocrystals were grown under the same con-tractive aspect of targeting NMNAT is that bacterial
ditions with the addition of 5 mM of NaAD to the protein solution.
NMNAT genes have been identified only very recently The complex crystals usually appeared within 1–2 weeks and had
[15], and no existing drugs have been developed to a cubic morphology. These crystals diffract to 1.9 A˚ resolution on
an in-house rotating anode X-ray source. The space group of thetarget NMNAT. The large differences in the active site
complex crystal was determined to be I222, with cell dimensionsarchitecture between bacterial and archaeal NMNAT in-
a  114.8 A˚, b  113.9 A˚, c  115.7 A˚,     
  90	. There aredicate that the archaeal NMNAT structure is a poor
three molecules in the asymmetric unit of the I222 cell. The solventmodel for the design of inhibitors for bacterial NMNAT.
content in both crystal forms was estimated to be 52%.
The high-resolution structures of bacterial NMNAT and For data collection, apo-ecNMNAT crystals were transferred step-
its complex with ligand described here present atomic wise to the cryoprotection solution containing the original reservoir
details of the active site and provide a foundation for solution and additional 20% glycerol. For the ecNMNAT-NaAD co-
crystals, 20% ethylene glycol was used as the cryoprotectant agent,the structure-based drug design. These structures also
since glycerol cracked the cocrystal instantly. Xe derivatization ofelucidated the structural mechanisms underlining the
apo-ecNMNAT crystals was also attempted. Although the phasespronounced preference for the deamidated NaMN over
from this Xe-treated crystal are negligible, we used this data set as
NMN by NMNATs from many bacteria, including the our native set because of its superior quality over other crystals.
majority of bacterial pathogens such as S. aureus, S. The native ecNMNAT data were collected at 100 K with a RAXIS IV
pneumoniae, and H. pylori. The distinct substrate prefer- image plate detector equipped with a Rigaku RU-H3R generator
and Osmic mirrors. A two wavelength (at peak and inflection pointence pattern of NMNATs from different organisms are
of Se K-edge) SeMet ecNMNAT MAD data set was collected atindicative of significant variations in the metabolite
beamline 19BM of the APS, Argonne National Laboratory. The statis-fluxes in the cell that lead to the NAD production. The
tics for all data sets are listed in Table 1.knowledge of relative importance of the specialized NAD
metabolic pathways in relevant organisms such as
Phasing and Refinement of apo-ecNMNAT
pathogens is important for the identification of potential The initial phases of the apo-ecNMNAT crystal structure were solved
drug target. Thorough enzymological and structural by the two wavelength MAD phasing method using the K-edge
characterizations of relevant bacterial NMNAT as well anomalous signal of the Se atoms. Twelve Se sites were found using
the heavy atom search routine in CNS [32] on the data collected atas its human counterpart are required for the modeling
the peak wavelength, which is consistent with four molecules in theof specific enzyme-effector interactions. We have re-
asymmetric unit and three Se sites in each molecule. The heavycently also solved the crystal structure of human NMNAT
atom parameters were then refined and the phases were calculated
(Zhou et al., submitted). A comparative analysis of hu- in CNS [32]. The figure of merit is 0.39 for data between 20 and 2.5 A˚
man and bacterial NMNAT structures is of crucial impor- resolution. The density modification procedure including solvent
tance for the design of highly selective NMNAT inhibitors flipping resulted in a much improved map, and the complete model
was built into the density using O [33]. The molecular average proce-with anti-infectious potential.
dures were also tried but the additional improvement of the map
was not significant.Experimental Procedures
The refinement was carried out in CNS [32]. Since large differences
are observed in the four independent ecNMNAT molecules, the non-Protein Overexpression and Purification
crystallographic symmetry (NCS) restraints were discarded after theThe cloning, expression, purification, and kinetic characterization
of E. coli NMNAT will be published elsewhere (Kurnasov et al., in first round of refinement. Simulated annealing refinement followed
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by several rounds of manual rebuilding resulted in an R factor of 2. Herceg, Z., and Wang, Z.Q. (2001). Functions of poly(ADP-
ribose) polymerase (PARP) in DNA repair, genomic integrity and25.2% and Rfree of 28.9%. At this stage, water molecules are included
using the water_pick routine of CNS using default parameters. The cell death. Mutat. Res. 477, 97–110.
3. Burkle, A. (2001). Poly(APD-ribosyl)ation, a DNA damage-drivencurrent refinement statistics are listed in Table 1. The final model
contains the entire ecNMNAT polypeptide chains (residues 1–213) protein modification and regulator of genomic instability. Can-
cer Lett. 163, 1–5.in molecules A and C. Residues 112–120 in molecule B and the C
terminus residue 213 in molecule D are disordered. Additionally, 4 4. Ziegler, M. (2000). New functions of a long-known molecule.
Emerging roles of NAD in cellular signaling. Eur. J. Biochem.Xe atoms and 585 water molecules have also been located.
267, 1550–1564.
Phasing and Refinement of the ecNMNAT-NaAD Complex 5. Moat, A.G., and Foster, J.W. (1987). Biosynthesis and salvage
The orthorhombic ecNMNAT-NaAD complex crystal structure was pathways of pyridine nucleotides. In Pyridine Nucleotide Coen-
solved by the molecular replacement method using AMoRe [34]. A zymes: Chemical Biochemical and Medical Aspects, Part B, Vol.
monomer of the apo-ecNMNAT was used as the search model. 2., D. Dolphin, ed. (New York: John Wiley and Sons), 1–24.
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a c.c. of 0.792 and R factor of 0.382. This model was subjected to the restein, P. (2001). The biosynthesis of nicotinamide adenine
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resulting electron density map. The NaAD structure, derived from imurium. J. Bacteriol. 155, 213–221.
the NAD in the HIC-UP database [35] was fitted into the electron 10. Natalini, P., Ruggieri, S., Raffaelli, N., and Magni, G. (1986).
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